HYDROXYCUT RECALL
Posted by: Micah Adkins
May 21, 2009
Topic: DANGEROUS DRUGS
The Food and Drug Administration (FDA) recently warned consumers using Iovate Health Sciences' diet supplement Hydroxycut to stop using the dietary supplement immediately. The Hydroxycut products marketed for energy and weight loss under the Iovate and MuscleTech trade names. An association between Hydroxycut products and serious renal issues, including liver and kidney injuries, has been demonstrated by several users of the dietary supplements.

One death case due to liver failure has been reported to the FDA and at least 23 adverse event reports (e.g., jaundice, elevated liver enzymes and liver damage requiring a liver transplant). Other symptoms of health problems reported to the FDA include seizures, cardiovascular disorders and rhabdomyolysis.
The FDA has not identified the ingredients, dosages, or other factors that are contributing to the above described risks related to the Hydroxycut. The FDA continues its investigation of the potential relationship between Hydroxycut dietary supplements and liver injury or other serious health problems.
Click here for the FDA's May 8, 2009 Press Release regarding the Hydroxycut recall.
If you, or a loved one, have purchased and consumed Hydroxycut and have suffered any of the above illnesses, then you may be entitled to money damages. Contact attorney Micah Adkins for a free and confidential consultation.
Attachments:
hydroxycut_samples.jpeg
News
NHTSA Recalls
[03/02] US BUS ( 10V095000 )
[03/02] TRANS TECH ( 10V094000 )
[03/01] SUTPHEN ( 10V092000 )
[03/01] TOYOTA ( 10V091000 )
[03/01] NEW FLYER ( 10V090000 )
Read More
Personal Injury
[03/12] Runaway Prius case presents nagging questions
[03/12] 2 killed, 2 injured in Salt Lake TRAX accident
[03/12] People with variable blood pressure at stroke risk
[03/12] Brake, driver problems cited in fatal Ariz. crash
[03/12] Experts say US doctors overtesting, overtreating
Read More
Pharmaceuticals
[03/12] AVEO Pharmaceuticals IPO prices below expectations
[03/12] Eisai says FDA approved new Dacogen dosing
[03/11] Pfizer says Sutent fails in breast cancer studies
[03/11] Watson says FDA approves 6-month dose Trelstar
[03/11] Astra boosts generic exposure with Torrent deal
Read More
Top Headlines
[03/12] Runaway Prius case presents nagging questions
[03/12] Court OKs TV rules opposed by Comcast, Cablevision
[03/12] OC prosecutor to sue Toyota over vehicle problems
[03/12] AG Holder didn't reveal all legal papers to Senate
[03/12] Maine man acquitted in 'lobster wars' trial
Read More
Topics
CAR ACCIDENTS
CONSUMER PROTECTION
DANGEROUS DRUGS
DEBTORS' RIGHTS
HURT AT WORK
ID THEFT, DATA BREACHES AND CREDIT REPORT DISPUTES
MOTORCYCLE WRECKS
SECURITIES LITIGATION
SOCIAL SECURITY BENEFITS
UNAUTHORIZED CHARGES
Recent Updates
September 15, 2009
TJX (TJ MAXX) SETTLES WITH BANKS OVER DATA BREACH
September 04, 2009
MERCK
August 24, 2009
Banks Reorder Transactions & Consumers Pay Insufficient Fund Fees
August 15, 2009
IS YOUR PRESCRIPTION INFORMATION REALLY PRIVATE?
August 11, 2009
TEXTING WHILE DRIVING INCREASES RISK OF CRASH
August 04, 2009
LIMITED BRANDS AND SKILLED HEALTHCARE GROUP INC POTENTIAL INVESTOR FRAUD
August 04, 2009
FDA WARNS OF HEALTH RISKS ASSOCIATED WITH E-CIGARETTES
July 06, 2009
CLASS ACTION SETTLEMENT NOTICE - SURIN & THE FAIR CREDIT REPORTING ACT
July 01, 2009
FDA Inspection Reveals Adulterated Synchromed? II Insulin Pumps
June 24, 2009
HOW DO I OBTAIN A FREE CREDIT REPORT?

